RITSUKO KOMAKI to Proto-Oncogene Proteins p21(ras)
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Proto-Oncogene Proteins p21(ras).
Connection Strength
0.050
-
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Res Commun. 2023 10 11; 3(10):2074-2081.
Score: 0.034
-
Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res. 2012 Mar 15; 18(6):1641-54.
Score: 0.015